Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8441650 | European Journal of Cancer | 2016 | 8 Pages |
Abstract
In GIST patients, presence of a KIT exon 11 mutation is an independent prognostic factor for PFS and OS, along with gender, PS, tumour size, lymphocyte and neutrophil counts. Subsets of exon 11 mutations are associated with significantly different response patterns and PFS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anna Patrikidou, Julien Domont, Sylvie Chabaud, Isabelle Ray-Coquard, Jean-Michel Coindre, Binh Bui-Nguyen, Antoine Adenis, Maria Rios, François Bertucci, Florence Duffaud, Christine Chevreau, Didier Cupissol, David Pérol, Jean-François Emile,